A myopic perspective on the future of protein diagnostics
New Biotechnology, ISSN: 1871-6784, Vol: 45, Page: 14-18
2018
- 7Citations
- 36Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations7
- Citation Indexes7
- CrossRef7
- Captures36
- Readers36
- 36
Review Description
Plasma proteome analyses of the future promise invaluable insights into states of health, not only by measuring proteins whose role it is to ensure blood homeostasis, but increasingly also as a window into the health of practically any tissue in the body via so-called leakage protein biomarkers. Realizing more of this vast potential will require progress along many lines. Here we discuss the main ones, such as optimal selection of target proteins, affinity reagents, immunoassay formats, samples, and applications, with a view from ongoing work in our laboratory.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1871678417305472; http://dx.doi.org/10.1016/j.nbt.2018.01.002; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85040442108&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/29309916; https://linkinghub.elsevier.com/retrieve/pii/S1871678417305472; https://dx.doi.org/10.1016/j.nbt.2018.01.002
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know